Vaccinex
A clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases. Learn more
Launch date
Employees
Market cap
$9.7m
Enterprise valuation
$11m (Public information from Sep 2024)
Share price
$4.55 VCNX
Rochester New York (HQ)
Authorizing premium user...